Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) Completed Phase 4 Trials for Poliomyelitis / Diphtheria / Acellular Pertussis / Tetanus / Viral Hepatitis B Prevention

Indications	Status	Purpose	Phase
DBCOND0013769 (Poliomyelitis) DBCOND0000394 (Diphtheria) DBCOND0031302 (Acellular Pertussis) DBCOND0000386 (Tetanus) DBCOND0048745 (Viral Hepatitis B)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00611559	Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (formaldehyde inactivated) (DB10992) Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (DB10991) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Hepatitis B Vaccine (Recombinant) (DB11627) Pentaerythritol tetranitrate (DB06154) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797)